Researcher.Life Logo

Expert Opinion on Drug Discovery : Impact Factor & More

eISSN: 1746-045XpISSN: 1746-0441

Aims and Scope of Expert Opinion on Drug Discovery

Expert Opinion on Drug Discovery is a monthly peer-reviewed medical journal publishing review articles on novel technologies involved in drug discovery. The editor-in-chief is David Janero from Northeastern University. Less

Key Metrics

CiteScore
8.5
Eigenfactor
0.005 - 0.01
Impact Factor
5 - 10
SJR
Q1Drug Discovery
SNIP
1.17
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Expert Opinion on Drug Discovery

Expert Opinion on Drug Discovery Journal Specifications

Overview
Publisher TAYLOR & FRANCIS LTD
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year2006
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Expert Opinion on Drug Discovery ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Expert Opinion on Drug Discovery

From mitochondrial signal to discovery decision: a reserve-demand framework for translational Risk assessment.
  • 30 Jun 2026
  • Expert opinion on drug discovery
Advances in 3D cell culture models for alzheimer’s disease drug discovery
  • 29 Jun 2026
  • Expert Opinion on Drug Discovery
Balancing optimism versus potential risks of AI-driven drug discovery
  • 26 Jun 2026
  • Expert Opinion on Drug Discovery
Trustworthy and explainable AI for drug discovery
  • 26 Jun 2026
  • Expert Opinion on Drug Discovery
Are patient-derived models of amyotrophic lateral sclerosis a game changer for novel drug discovery?
  • 25 Jun 2026
  • Expert Opinion on Drug Discovery
Unfolding prion misfolding and the challenge of identifying effective therapeutics: is there hope on the horizon?
  • 21 Jun 2026
  • Expert Opinion on Drug Discovery
From mitochondrial signal to discovery decision: a reserve-demand framework for translational Risk assessment.
  • 30 Jun 2026
  • Expert opinion on drug discovery
Advances in 3D cell culture models for alzheimer’s disease drug discovery
  • 29 Jun 2026
  • Expert Opinion on Drug Discovery
Balancing optimism versus potential risks of AI-driven drug discovery
  • 26 Jun 2026
  • Expert Opinion on Drug Discovery
Trustworthy and explainable AI for drug discovery
  • 26 Jun 2026
  • Expert Opinion on Drug Discovery
Are patient-derived models of amyotrophic lateral sclerosis a game changer for novel drug discovery?
  • 25 Jun 2026
  • Expert Opinion on Drug Discovery
Unfolding prion misfolding and the challenge of identifying effective therapeutics: is there hope on the horizon?
  • 21 Jun 2026
  • Expert Opinion on Drug Discovery

FAQs on Expert Opinion on Drug Discovery